Each year, 11 million people worldwide develop tuberculosis, and about 1.4 million die from it. Meningitis occurs in 1–2% of patients and is the most severe complication of tuberculosis, arising when ...
Tuberculous meningitis (TBM) arises when Mycobacterium tuberculosis disseminates to the meninges, provoking an intense inflammatory response that can lead to raised intracranial pressure, ...
Tuberculosis (TB) remains one of humanity’s oldest and most persistent health challenges. Despite significant medical advances, this infectious disease continues to affect millions globally, with ...
Each year, 11 million people worldwide develop tuberculosis, and about 1.4 million die from it. Meningitis occurs in 1–2% of patients and is the most severe complication of tuberculosis, arising when ...
A trial of a new drug regimen to treat tuberculous meningitis (TBM) has started enrolling adults and adolescents in several countries where tuberculosis (TB) is prevalent. The Improved Management with ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. We're so lucky to ...
Tuberculosis (TB) infects about 11 million people globally each year and causes 1.4 million deaths. The most severe complication—tuberculous meningitis—occurs when TB bacteria reach the brain.
Hosted on MSN
High-dose antibiotic does not reduce mortality in tuberculous meningitis, clinical trial finds
A higher dose of the antibiotic rifampicin does not improve survival rates for patients with tuberculous meningitis. This severe form of tuberculosis causes inflammation of the brain membranes, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results